» Articles » PMID: 34552183

The Development of Tumour Vascular Networks

Overview
Journal Commun Biol
Specialty Biology
Date 2021 Sep 23
PMID 34552183
Citations 8
Authors
Affiliations
Soon will be listed here.
Abstract

The growth of solid tumours relies on an ever-increasing supply of oxygen and nutrients that are delivered via vascular networks. Tumour vasculature includes endothelial cell lined angiogenesis and the less common cancer cell lined vasculogenic mimicry (VM). To study and compare the development of vascular networks formed during angiogenesis and VM (represented here by breast cancer and pancreatic cancer cell lines) a number of in vitro assays were utilised. From live cell imaging, we performed a large-scale automated extraction of network parameters and identified properties not previously reported. We show that for both angiogenesis and VM, the characteristic network path length reduces over time; however, only endothelial cells increase network clustering coefficients thus maintaining small-world network properties as they develop. When compared to angiogenesis, the VM network efficiency is improved by decreasing the number of edges and vertices, and also by increasing edge length. Furthermore, our results demonstrate that angiogenic and VM networks appear to display similar properties to road traffic networks and are also subject to the well-known Braess paradox. This quantitative measurement framework opens up new avenues to potentially evaluate the impact of anti-cancer drugs and anti-vascular therapies.

Citing Articles

Endogenous bystander killing mechanisms enhance the activity of novel FAP-specific CAR-T cells against glioblastoma.

Yu W, Truong N, Polara R, Gargett T, Tea M, Pitson S Clin Transl Immunology. 2024; 13(7):e1519.

PMID: 38975278 PMC: 11225608. DOI: 10.1002/cti2.1519.


The in vitro dynamics of pseudo-vascular network formation.

Oraiopoulou M, Couturier D, Bunce E, Cannell I, Sweeney P, Naylor H Br J Cancer. 2024; 131(3):457-467.

PMID: 38902534 PMC: 11300916. DOI: 10.1038/s41416-024-02722-7.


Incorporating temporal information during feature engineering bolsters emulation of spatio-temporal emergence.

Cain J, Evarts J, Yu J, Bagheri N Bioinformatics. 2024; 40(3).

PMID: 38444088 PMC: 10957516. DOI: 10.1093/bioinformatics/btae131.


Synthesis, Characterizations, and Quantum Chemical Investigations on Imidazo[1,2-]pyrimidine-Schiff Base Derivative: ()-2-Phenyl--(thiophen-2-ylmethylene)imidazo[1,2-]pyrimidin-3-amine.

Azzouzi M, Azougagh O, Ouchaoui A, El Hadad S, Mazieres S, El Barkany S ACS Omega. 2024; 9(1):837-857.

PMID: 38222514 PMC: 10785637. DOI: 10.1021/acsomega.3c06841.


Radiomics characterization of tissues in an animal brain tumor model imaged using dynamic contrast enhanced (DCE) MRI.

Bagher-Ebadian H, Brown S, Ghassemi M, Nagaraja T, Movsas B, Ewing J Sci Rep. 2023; 13(1):10693.

PMID: 37394559 PMC: 10315398. DOI: 10.1038/s41598-023-37723-8.


References
1.
Kim K, Spencer S, Albeck J, Burke J, Sorger P, Gaudet S . Systematic calibration of a cell signaling network model. BMC Bioinformatics. 2010; 11:202. PMC: 2880028. DOI: 10.1186/1471-2105-11-202. View

2.
Dorraki M, Allison A, Abbott D . Truels and strategies for survival. Sci Rep. 2019; 9(1):8996. PMC: 6586887. DOI: 10.1038/s41598-019-45253-5. View

3.
Yang J, Liao Y, Mai D, Xie P, Qiang Y, Zheng L . Tumor vasculogenic mimicry predicts poor prognosis in cancer patients: a meta-analysis. Angiogenesis. 2016; 19(2):191-200. DOI: 10.1007/s10456-016-9500-2. View

4.
Wagner A, Fell D . The small world inside large metabolic networks. Proc Biol Sci. 2001; 268(1478):1803-10. PMC: 1088812. DOI: 10.1098/rspb.2001.1711. View

5.
Humphries M, Gurney K . Network 'small-world-ness': a quantitative method for determining canonical network equivalence. PLoS One. 2008; 3(4):e0002051. PMC: 2323569. DOI: 10.1371/journal.pone.0002051. View